Massage therapy for osteoarthritis of the knee: A randomized controlled trial

Archives of Internal Medicine

Volumn 166, Issue 22, 2006, Pages 2533-2538

  Perlman, Adam I ^a,c   Sabina, Alyse ^b   Williams, Anna Leila ^b   Njike, Valentine Yanchou ^b   Katz, David L ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b Yale Griffin Prevention Research Center   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MASSAGE; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; RIGIDITY; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MASSAGE; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; TREATMENT OUTCOME;

EID: 33845489120     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.22.2533     Document Type: Article

References (40)

1. Felson DT, Lawrence RC, Hochberg MC, et al. Osteoarthritis: new insights, II: treatment approaches. Ann Intern Med. 2000;133:726-737.
2. Praemer A, Furner S, Rice DP. Musculoskeletal Conditions in the United States. Rosemont, Ill: American Academy of Orthopaedic Surgeons; 1999.
3. Baird CL. First-line treatment for osteoarthritis, I: pathophysiology, assessment, and pharmacologic interventions. Orthop Nurs. 2001;20:17-27.
4. Fajardo M, Di Cesare PE. Disease-modifying therapies for osteoarthritis: current status. Drugs Aging. 2005;22:141-161.
5. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006;20:3-25.
6. Elders MJ. The increasing impact of arthritis on public health. J Rheumatol. 2000;60(suppl):6-8.
7. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778-799.
8. Felson DT. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am. 2004;42:1-9.
9. National Center for Health Statistics. Health, United States 2005 with chartbook on trends in the health of Americans. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nchs/data/hus/hus0.5.pdf. Accessed April 10, 2006.
10. Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clin Orthop. 2004;427(suppl):S6-S15.
11. Kato T, Xiang Y, Nakamura H, Nishioka K. Neoantigens in osteoarthritic cartilage. Curr Opin Rheumatol. 2004;16:604-608.
12. Matchaba P, Gitton X, Krammer G, et al. Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials ≥1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis. Clin Ther. 2005;27:1196-1214.
13. Naesdal J, Brown K. NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options. Drug Saf. 2006;29:119-132.
14. Nayak S, Matheis RJ, Agostinelli S, Shifleft SC. The use of complementary and alternative therapies for chronic pain following spinal cord injury: a pilot survey. J Spinal Cord Med. 2001;24:54-62.
15. Ernst E. Complementary and alternative medicine for pain management in rheumatic disease. Curr Opin Rheumatol. 2002;14:58-62.
16. Preyde M. Effectiveness of massage therapy for subacute low-back pain: a randomized controlled trial. CMAJ. 2000;162:1815-1820.
17. Altman R, Asch E, Bloch D, et al; Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum. 1986;29:1039-1049.
18. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-1840.
19. Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ; Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial [published correction appears in JAMA. 2002;287:989]. JAMA. 2002;287:64-71.
20. American Massage Therapy Association. Glossary of terms. American Massage Therapy Association Web site. http://www.amtamassage.org/about/terms.html. Accessed April 10, 2006.
21. Taylor AG, Galper DI, Taylor P, et al. Effects of adjunctive Swedish massage and vibration therapy on short-term postoperative outcomes: a randomized, controlled trial. J Altern Complement Med. 2003;9:77-89.
22. Wieting JM, Cugalj AP. Massage, traction and manipulation. http://www.emedicine.com/pmr/topic200.htm. Accessed April 10, 2006.
23. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum. 1985;28:542-547.
24. Bellamy N. Outcome measurement in osteoarthritis clinical trials. J Rheumatol Suppl. 1995;43:49-51.
25. Brattberg G. Connective tissue massage in the treatment of fibromyalgia. Eur J Pain. 1999;3:235-244.
26. Field T, Hernandez-Reif M, Seligman S, et al. Juvenile rheumatoid arthritis: benefits from massage therapy. J Pediatr Psychol. 1997;22:607-617.
27. Sunshine W, Field TM, Quintino O, et al. Fibromyalgia benefits from massage therapy and transcutaneous electrical stimulation. J Clin Rheumatol. 1996;2:18-22.
28. Witt C, Brinkhaus B, Jena S, et al. Acupuncture in patients with osteoarthritis of the knee: a randomised trial. Lancet. 2005;366:136-143.
29. Dalessio DJ. Editorial: studies on pain and the hawthorne effect. Headache. 1974;14:109-110.
30. Holden JD. Hawthorne effects and research into professional practice. J Eval Clin Pract. 2001;7:65-70.
31. Hogenmiller MS, Lozada CJ. An update on osteoarthritis therapeutics. Curr Opin Rheumatol. 2006;18:256-260.
32. Hogue JH, Mersfelder TL. Pathophysiology and first-line treatment of osteoarthritis. Ann Pharmacother. 2002;36:679-686.
33. Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 2004;26:1774-1782.
34. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med. 1994;331:1675-1679.
35. Ernst E. Musculoskeletal conditions and complementary/alternative medicine. Best Pract Res Clin Rheumatol. 2004;18:539-556.
36. Nayak S, Matheis RJ, Schoenberger NE, Shiflett SC. Use of unconventional therapies by individuals with multiple sclerosis. Clin Rehabil. 2003;17:181-191.
37. Ramsey SD, Spencer AC, Topolski TD, et al. Use of alternative therapies by older adults with osteoarthritis. Arthritis Rheum. 2001;45:222-227.
38. Setty AR, Sigal LH. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum. 2005;34:773-784.
39. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795-808.
40. Berman BM, Lao L, Langenberg P, Lee WL, Gilpin AMK, Hochberg MC. Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med. 2004;141:901-910.